T HERE IS CONSIDERABLE ethical and legal ambiguity surrounding the role of adolescents in the decisionmaking process for research participation. Depending on the nature of the study and the regulations involved, adolescents may have independent responsibility for providing informed consent, they may be asked to provide their assent, or they may be completely excluded from the decision process. 1,2 The extent to which adolescents' opinions concerning research participation are actually solicited and honored depend on factors such as family decision-making styles and preferences; beliefs about the importance of adolescent autonomy; perceived risks and benefits of the research study; and perceptions of adolescent judgment, maturity, and cognitive ability. 3, 4 Some have commented on the reluctance of the medical community and parents to recognize mature children and adolescents as having decision-making capacity. They note that a lack of clarity concerning the rules and confusion about the basis for assent or dissent of a child with developing decision-making ability may limit participation in research decisions. 5, 6 For example, Department of Health and Human Services regulations allow for parental waivers in certain situations, whereas the Food and Drug Administration (FDA) regulations do not. 1, 2 The degree to which parents and adolescents influence one another and the extent to which they consider the opinions of physicians in the research participation decision-making process have received little empirical attention. Preliminary evidence suggests that both parents and adolescents claim decision-making responsibility for research participation decisions. 4 Parents in this study were willing to consider their adolescents' opinions but expected that adolescents would acquiesce to their decision. However, adolescents seemed less amenable to parental influence, and indicated they would not have to follow their parents' wishes. Parents are known to exert greater decision-making control over younger adolescents, especially daughters. [7] [8] [9] Findings from focus group research on parent-adolescent need for parental consent for research participation found that older adolescents saw significantly less need for parental consent than did their parents for research on sensitive topics, such as sexuality and drug and alcohol use. 10 The purpose of the present study was to examine parent and adolescent perceptions of responsibility for adolescent research participation decisions and to examine the role of adolescents, parents, and physicians as sources of decision-making influence. We hypothesized that parents would overestimate their adolescents' willingness to acquiesce to parental decisions, that both parents and adolescents would view physicians as an important source of decision-making influence, and that adolescent boys would have more influence over parents than would adolescent girls.
METHODS

Design and Setting
We presented 9 vignettes describing a variety of pediatric asthma research studies to adolescent-parent dyads. Consent and assent procedures for this study were reviewed and approved by the Health Sciences Center Human Research Review Committee. All of the participants were recruited from a university-affiliated children's hospital pediatric pulmonary outpatient clinic that serves as the statewide referral center for children with asthma. Families were approached during a clinic visit and given a brief discussion of the study. For those agreeing to participate, a separate appointment was made to conduct the research at an office located outside the medical clinic.
Participants
Parent-adolescent dyads were eligible to participate if the adolescent was between 11 and 18 years of age and had a previous diagnosis of asthma. Only English-speaking families were enrolled.
Measures
Parents completed a 15-item demographic form and a 33-item asthma history questionnaire developed from the Guidelines for the Diagnosis and Management of Asthma 11 and also included questions pertaining to the adolescent's current medication regimen. Parents were asked about previous participation in asthma research studies and about the frequency of various asthma procedures that had been completed by the adolescent in the preceding 12 months (eg, spirometry, allergy/skin testing, and venipuncture).
Research Vignettes
Forty consent forms describing previously conducted publicly and privately funded studies from the 1990s and 2000 were obtained from pediatric asthma researchers in the United States and England. Consent forms were obtained in 2 ways. Prominent researchers known to the authors were contacted directly to request copies of their consent forms. Other researchers were identified via a Medline literature review of recently published pediatric asthma studies. Requests for consent forms were made to all of those for whom contact information was available. Specific attempts were made to obtain consent forms for studies that involved varied designs and procedural elements. An expert panel of 8, consisting of physicians, clinical pharmacists, and psychologists with expertise in ethics, pediatric asthma research, or both, evaluated the consent forms and selected a representative sample of 9 studies. The studies were selected based on unanimous ratings of risk and unique protocol design. The 5 minimal risk protocols included: a 1-month study examining the impact of an approved asthma medication on participants' ability to learn in school; a 3-year study monitoring symptoms of adolescents with mild-to-severe asthma; an 18-month evaluation of 3 educational methods for helping adolescents control asthma; a 1-day study examining the use of using high resolution computer tomography in asthma research; and a 36-hour observational study evaluating nitric oxide and cortisol levels during an overnight hospital stay. The 4 above minimal risk studies included: a 15-week clinical trial comparing 2 FDA-approved medications using a double-blind, double-dummy placebo crossover design; a 26-week medication trial examining fixed versus as-needed dosing for an established asthma medication; a 5-year clinical trial comparing 2 non-FDA-approved medications versus placebo; and a 4-month study involving methacholine challenge to evaluate the use of sputum induction findings for asthma treatment. 12 Key information for each of the selected protocols was extracted from the consent form and rewritten into a 1-page standardized research vignette format. Each included an informative study title, a brief statement of the reason for the study, and details of the length and time required for participation. To facilitate presentation of multiple vignettes, procedures were summarized in bullet format. Risks of the procedures were described in an earlier part of the study and were available to participants during presentation of the vignettes. The medication trials included a description of medications and their known risks/adverse effects. A description of study incentives was included at the end of each vignette. See Table 1 for a sample vignette.
Study Protocol
Parents and adolescents met together with a research assistant to review and sign informed consent and assent documents. Family members were then separated for independent data collection. Participants were first asked to evaluate the risks and benefits associated with 10 common asthma research procedures, such as spirometry, allergy skin testing, methacholine challenge, and experimental medication. These findings are presented elsewhere. 13 The 9 vignettes describing the research protocols were then presented to participants. Alternate presentation orders were established for each parent-adolescent dyad using a standard Latin square design procedure. For each of the 9 research vignettes, adolescents and parents were asked an identical series of 12 questions. Respondents were asked for a dichotomous (yes or no) response concerning their willingness to enroll in the research protocol described in each vignette. The remaining questions were evaluated on a 7-point Likert scale. In addition to willingness to participate, the questions asked about perceptions of the other family member's (parent or adolescent) willingness to participate, perceptions of responsibility for the participation decision, influence of family member and physician views on their decisions, and their overall evaluation of the risks, benefits, discomfort, hassle, and appropriateness of compensation offered for participation in the protocol. Previously published findings from this set of questions include data comparing family members' willingness to participate in each of the protocols 12 and perceptions of fair compensation for participation. 14 The results presented here compare parent and adolescent perceptions of family member authority and influence versus physician influence on the research participation decision.
Data Analyses
Data were analyzed using 2 separate full-factorial multivariate analyses of variance (MANOVA). The first set of analyses compared parent and adolescent perceptions of responsibility for the research participation decision. The second set of analyses compared parent and adolescent perceptions of the influence of family members versus physicians on research participation decisions. Preliminary analyses examining adolescent age and gender effects indicated that age was not significantly related to the dependent measures. However, adolescent gender was retained in subsequent analyses of the findings.
To compare parent and adolescent perceptions of responsibility for adolescent research participation decisions, we computed mean scores across the vignettes based on parent responses to the 7-point Likert scale question, "Would your child agree to whatever you thought was best?" and adolescent responses to the Research studies often pay participants. Payment may be offered for several things including: • The time it takes to participate.
• The effort it takes to complete the study.
• Any inconvenience involved in completing this study.
• Reimbursement for expenses like meals, transportation, and parking. You will receive a total of $105.00 for participating in this study. Summary:
This study requires 8 brief visits to the medical clinic over 3 years, completing a few medical tests, and questionnaires, as mentioned above. You will receive a total of $105.00 for participating in this study.
question, "Would you have to do what your parent(s) decided?" Separate minimal risk means were computed from parent and adolescent responses to the 5 minimal risk vignettes. Similarly, separate above minimal risk means were computed from parent and adolescent responses to the 4 above minimal risk vignettes. We then conducted a gender ϫ family member ϫ protocol risk level mixed-effects MANOVA on these mean scores. Adolescent gender was the between-participants variable. Risk (minimal or above minimal) and family member (parent or adolescent) were treated as within-participant repeated measure factors. Perceptions of influence on the research participation decision were evaluated from parent and adolescent responses to 2 questions. Parents responded to the questions, "Could your child's opinion change your mind (about research participation)?" and "Could the opinion of your child's doctor change your mind?" Adolescents responded to the questions, "Could your parent's opinion change your mind?" and "Could your doctor's opinion change your mind?" A gender ϫ protocol risk ϫ family member ϫ influence source mixed-effects MANOVA was conducted with adolescent gender as the between-participants variable and protocol risk (minimal or above minimal), family member (parent or adolescent), and influence source (family or physician) as the repeated measures.
To ensure that participants' evaluations of the level of protocol risk matched those of the expert panel, we also conducted a protocol risk (minimal or above minimal) by family member (parent or adolescent) analysis of variance and the question, "How risky is this study to you?" (Parents responded to the question, "How risky is this study for your child?") RESULTS Thirty-six adolescent-parent dyads participated in this study. Two families who had indicated earlier interest later declined to participate. Demographic information for the sample is presented in Table 2 .
Analyses of the participants' perceptions of protocol risk demonstrated that adolescents and parents agreed with the expert panel's ratings of risk. The minimal risk protocols were rated less risky than the above minimal risk protocols (P ϭ .000).
Findings revealed significant differences in the perception of decision-making responsibility between parents and adolescents. Across all of the research vignettes, parents anticipated that adolescents would yield to their decisions, whereas adolescents reported significantly less willingness to yield to parental decisions concerning research participation (P ϭ .022).
Concerning perceptions of influence on the research decision, results revealed significant main effects for family member, protocol risk, and influence source, with no significant effects for gender. Overall, parents reported greater willingness than adolescents to change their minds about research participation based on outside opinion (P ϭ .003; parent mean: 4.83; adolescent mean: 3.84). The significant protocol risk effect indicated that both parents and adolescents were more open to outside influence on above minimal risk studies than on minimal risk studies (P ϭ .041; above minimal risk mean: 4.53; minimal risk mean: 4.15). The findings also revealed that, overall, parents and adolescents could be more influenced in their decision by a physician than by a family member (P ϭ .028; physician mean: 4.56; family member mean: 4.12).
Three significant interaction effects were also observed. First, both parents and adolescents were more likely to accept outside influence on the participation decision for above minimal risk studies when the adolescent was female. When the adolescent was male or the study was minimal risk, both parents and adolescents were less likely to accept outside opinions (P ϭ .028). Figure 1 depicts this significant protocol risk by adolescent gender effect.
Second, for both parents and adolescents, physician opinion was more influential than family member views in above minimal risk studies, but not in the minimal risk studies (P ϭ .006). This significant protocol risk by influence source interaction is shown in Fig 2. Finally, as shown in Fig 3, results revealed that when the influence source was the physician, parents would be more likely to change their minds than would adolescents, regardless of adolescent gender. However, when the influence source was the family, parents were significantly more willing to be influenced by their adolescent when the adolescent was male than when the adolescent was female (P ϭ .011).
DISCUSSION
Adolescent participation in research decisions is an important ethical imperative. However, little is known about how families actually make these decisions, what level of involvement adolescents have or desire to have in the decision-making process, and what factors influence how research participation decisions are actually made. To address some of these important ethical questions, this study compared the views of adolescent-parent dyads concerning their beliefs about who maintains authority within the family to make research participation decisions for the adolescent. Opinions concerning family and physician influence over participation decisions were also evaluated. Adolescent responses differed from those of their parents in several important ways. The young adolescents in this sample expressed a relative unwillingness to cede decision-making authority to parents, although parents believed their adolescents would be agreeable to and comply with parental wishes. This is consistent with our earlier research, 4 verifying a preference among adolescents for greater decision-making autonomy in asthma research. Moreover, this finding corresponds with current psychological perspectives on adolescent development of emotional and behavioral autonomy. Although parents exert considerable control over young adolescents, especially girls, 7-9 as they mature, older adolescents assume greater responsibility for decisions affecting their personal life and perceive themselves as more capable of resisting social influence in decision-making situations. 9, 15, 16 That even young adolescents report a desire to exercise autonomy in research-related decisions, such as those presented in this study, may reflect a special value placed on matters of personal control over health behaviors, particularly when they involve the use of medications with unpleasant adverse effects or uncomfortable medical procedures.
Although there is a growing consensus among scholars that children ought to have more input into research participation decision-making, principally for nonbeneficial research, 17, 18 our data suggest that parents do not necessarily share this view. Parents have already voiced concerns about health care policies that protect adolescent confidentiality. 19 If they believe research decisions are primarily in their purview, parents are likely to voice dissent with attempts to enhance research decisionmaking autonomy for children and adolescents. Differences of opinion among family members may also create ethical quandaries for investigators enrolling adolescents in research, particularly for girls, because adolescent boys seem to be granted more autonomy by parents to make research decisions.
The likeliest scenario for disagreement is one in which the adolescent desires to participate and the parent prefers to decline. This is particularly true for above minimal risk studies. We have demonstrated elsewhere 12 that adolescents are more willing to enroll in above minimal risk asthma research than parents are willing to permit their enrollment. Were adolescents to obtain greater autonomy in research participation decision-making, enrollment in these studies might proceed more quickly. However, the ability of adolescents to appropriately weigh research risks and benefits in the context of an actual clinical trial has not yet been empirically established, although it has been demonstrated in analog vignette studies. 20 As data accumulates on the desire, ability, and process by which adolescents may exercise autonomy in research participation decision-making, the issue of parental versus adolescent rights in these decisions may emerge at the forefront of the discussion, with the courts as ultimate arbiters. Clarifying the perspectives of family members helps to explain the potential legal and ethical issues at stake.
FIGURE 1
Parent and adolescent willingness to be influenced in research decisions based on level of protocol risk and gender of adolescent. Full Likert scale range in from 1 (not at all) to 7 (a lot).
FIGURE 2
Parent and adolescent willingness to be influenced in research decisions based on level of protocol risk and source of influence. Full Likert scale range is from 1 (not at all) to 7 (a lot).
Our finding concerning the willingness of adolescents and parents to consider the opinions of family members and physicians lends further nuance to the influence of personal versus professional relationships in research participation decisions. In general, parents reported more willingness than adolescents to be influenced by others in asthma research participation decisions. Both parents and adolescents acknowledged a greater openness to input from others when considering above minimal risk rather than minimal risk studies, and both groups also acknowledged that physician's views would be more persuasive than family members' views. However, there were important clarifications to these findings. Physician influence would be strongest when considering participation in above minimal risk asthma studies. Moreover, physicians would have the greatest influence on both parents and adolescents when the adolescent was female.
Overall, these findings demonstrate the importance of physician recommendations for parent and adolescent decision-making. Both parents and adolescents recognized the increase risk associated with protocols rated by our experts as above minimal risk, and they also reported greater interest in physician's views of these studies. This suggests that families may feel less able to appropriately judge the risks and benefits of above minimal risk studies and will look to their personal physicians for guidance. Many above minimal risk studies offer little direct benefit to participants, and participants can be expected to conflate research with medical care, a process well documented as the therapeutic misconception. 21, 22 Thus, physician guidance may be particularly important in clarifying the purpose of and limits to the benefits of research participation. Commentators have identified a number of complex considerations related to the ethical involvement of physicians in research participation decisions, including limitations in professional integrity, conflicts of interest, and disparities of social power that may operate to limit participant autonomy and inappropriately influence participant decisionmaking. [23] [24] [25] [26] Nonetheless, our findings highlight that physician guidance is important to families contemplating research participation. Although no data directly address physician influence, trust in physicians has been identified as an important factor in some research participation decisions 4, 27 and the physician as advisor may be especially important to adolescents as they begin to exercise greater independence from parents on both medical and research participation decisions.
Thus, physicians can be expected to play a key role in research decisions concerning adolescents. In recognition of this important role, steps can be taken by researchers, physicians, and institutions to facilitate the ethical enrollment of adolescents into biomedical research. Researchers can establish methods of physician dialogue with adolescents that enhance adolescent knowledge and appreciation of research participation, whereas simultaneously preserving and respecting their developing autonomy. Individual physicians can reflect on their own multiple roles within an institution, carefully considering conflicts of interest that may influence their behavior toward potential research participants. Institutions can take a proactive approach in each of these areas, incorporating education on developmental issues in research participation decision-making into ongoing research ethics training programs, establishing policy guidance related to potential conflicts of interest, creating a research culture that values participant autonomy in decision-making, and ensuring appropriate oversight. Taken together, these measures can provide an important ethical foundation for the enrollment of all participants into biomedical research and facilitate the appropriate involvement of adolescents in research participation decision-making.
There are several limitations to this research that should be noted. Participants evaluated only asthma protocols. Responses to protocols related to other diseases, especially for research related to terminal rather than chronic illnesses, may be different. Our sample was relatively small, and recruitment occurred from a single medical site and did not include all racial groups. Participants located in other geographical regions and from
FIGURE 3
Differences in parent and adolescent willingness to be influenced by others based on influence source and adolescent gender. A, Influence from physician. B, Influence from family. Parents rate influence from adolescents and adolescents rate influence from parents. Full Likert scale range is from 1 (not at all) to 7 (a lot).
